In myeloma, the sensitivity of cells to venetoclax is strongly associated with the t (11, 14) translocation, since it more likely presents with high BCL2 expression and low MCL1 or BCL-XL expression [10]. This evidence concerns the gene MCL1 and plasma cell myeloma.